Company / EPS (Diluted)
Cocrystal Pharma, Inc. EPS (Diluted) History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.17
FY2021
5-year range
-$1.75 / -$0.11
FY2017-FY2021
Trend
+88.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.75 to $-0.17 over the past 2 years.
Based on SEC 10-K filings.
-0.17 in FY2021.
Improved from $-1.75 to $-0.17 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, eps (diluted) increased 88.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$0.17 | +88.7% |
| FY2020 | -$1.51 | +13.7% |
| FY2019 | -$1.75 | -1490.9% |
| FY2012 | -$0.11 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026